Paris - Delayed Quote EUR
Inventiva S.A. (IVA.PA)
2.9250
+0.0250
+(0.86%)
At close: June 13 at 5:35:03 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-85,928
-85,928
-81,614
-44,928
-47,629
Investing Cash Flow
8,745
8,745
-7,731
8,868
-1,793
Financing Cash Flow
145,592
145,592
29,081
37,268
25,447
End Cash Position
96,564
96,564
26,918
86,736
86,553
Capital Expenditure
-333
-333
-540
-561
-534
Issuance of Capital Stock
57,338
57,338
30,589
8,827
25,475
Issuance of Debt
24,916
24,916
0
30,209
0
Repayment of Debt
-4,992
-4,992
-4,097
-1,768
-28
Free Cash Flow
-86,261
-86,261
-82,154
-45,489
-48,163
12/31/2021 - 2/15/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688382.SS InventisBio Co., Limited
34.82
-2.74%
NKB2.F TG Therapeutics, Inc.
31.89
-0.92%
ABVX.PA ABIVAX Société Anonyme
5.79
-7.36%
ALCOX.PA Nicox S.A.
0.2205
-2.86%
OXUR.BR Oxurion NV
0.0418
-5.86%
POXEL.PA Poxel S.A.
0.6380
-3.19%
5CV.MU CureVac NV
4.7540
+0.72%
1CG.SG CRISPR Therapeutics AG
35.60
+0.56%
ARGX.BR argenx SE
502.60
-0.63%
22UA.DE BioNTech SE
91.65
+0.22%